Home > Boards > US Listed > Medical - Healthcare > Iovance BiotherapeutIcs (IOVA)

$IOVA Daily Chart: Maybe a short play here imo...

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Golden_Cross Member Profile
Member Level 
Followed By 1,871
Posts 49,768
Boards Moderated 52
Alias Born 10/05/05
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2020 5:01:57 PM
Iovance Biotherapeutics to Present at Upcoming Conferences GlobeNewswire Inc. - 3/2/2020 4:01:10 PM
Annual Report (10-k) Edgar (US Regulatory) - 2/25/2020 5:14:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2020 4:11:44 PM
Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 2/25/2020 4:01:10 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/24/2020 4:18:11 PM
Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Tuesday, F... GlobeNewswire Inc. - 2/19/2020 7:00:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 4:03:58 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/14/2020 1:44:01 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 10:04:43 AM
Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences GlobeNewswire Inc. - 2/12/2020 7:00:10 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/11/2020 4:42:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/5/2020 4:32:44 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2020 11:49:50 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/4/2020 4:56:03 PM
Iovance Biotherapeutics Completes Patient Dosing in Registration-Enabling Cohort 4 of the C-144-01 Melanoma Study with Lifile... GlobeNewswire Inc. - 1/15/2020 8:00:10 AM
Iovance Shares Down 10% After Licensing Drug From Novartis Dow Jones News - 1/13/2020 1:12:00 PM
Iovance Biotherapeutics Obtains License to Develop and Commercialize a Novel IL-2 Analog GlobeNewswire Inc. - 1/12/2020 4:30:10 PM
Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement GlobeNewswire Inc. - 1/12/2020 4:00:10 PM
Iovance Biotherapeutics to Present at Upcoming Investor Conferences in December GlobeNewswire Inc. - 12/2/2019 7:00:10 AM
Iovance Biotherapeutics Announces Results of a Subgroup Analysis of Patients in the Lifileucel Metastatic Melanoma Study who ... GlobeNewswire Inc. - 11/21/2019 7:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 1:20:15 PM
Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society ... GlobeNewswire Inc. - 11/8/2019 7:00:00 AM
Iovance Biotherapeutics to Present at Upcoming Investor Conferences in November GlobeNewswire Inc. - 11/7/2019 4:32:49 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2019 5:03:40 PM
Golden_Cross Member Level  Thursday, 04/11/19 05:50:42 PM
Re: None
Post # of 59 
$IOVA Daily Chart: Maybe a short play here imo...



Lets exchange member marks and exchange market moving information today!

All my posts are strictly my opinion only! Please do your own DD.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist